Van Gorder Scripps Banner

The Objective Path to System-Wide,
Evidence-Based Healthcare Management


15 top health systems logo

The Truven Health 15 Top Health Systems study is the only study of its kind to aggregate rigorous analysis of individual hospital performance metrics into system-level data that identifies the 15 best health systems in the nation. This annual, quantitative study uses objective, independent research and public data sources. Health systems do not apply for consideration, and winners do not pay to market their award.

Our highly coveted 15 Top Health Systems study provides healthcare executives and boards of directors with crucial, evidence-based insights into the effectiveness of health system leadership, organizational performance, and management alignment.

Building on the Truven Health 100 Top Hospitals® balanced scorecard concept, this research allows health system leaders to understand how they compare to both peers and national benchmarks in terms of quality of care, operations, and patient satisfaction.

2016 15 Top Health Systems Award Winners Announced April 25, 2016

The winners of this year’s 15 Top Health Systems award outperformed their peers in a number of ways. They:

  • Saved more lives and caused fewer patient complications
  • Followed industry-recommended standards of care more closely
  • Released patients from the hospital a half-day sooner
  • Readmitted patients less frequently and experienced fewer deaths within 30 days of admission
  • Had over 12 percent shorter wait times in their emergency departments
  • Had nearly 5 percent lower Medicare beneficiary cost per 30-day episode of care
  • Scored over 7 points higher on patient overall rating of care

New Performance Measures

Our study continues to adapt as the healthcare industry changes. We are currently analyzing several new performance measures for information only. Even though they were not used to rank health system performance, differences were identified using the new metrics. Benchmark systems had:

  • 28 percent fewer patients with mrsa infections
  • 23 percent fewer patients with catheter-associated urinary tract infections
  • coronary artery bypass grafting 30-day mortality and readmission rates that were 0.5 and 0.7 percentage points lower
  • 30-day episode payment costs from 2 to 5 percent lower
  • operating margins that were nearly 1 percent higher
Watch for our 2017 study release in April 2017.

 

Read Our Study

Download a Sample Report